{"id":"qlc5508","safety":{"commonSideEffects":[{"rate":null,"effect":"unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"QLC5508 works by binding to the molecular target, which leads to a specific therapeutic effect.","oneSentence":"QLC5508 is a small molecule drug that targets the molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:52:07.052Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"unknown"}]},"trialDetails":[{"nctId":"NCT07463573","phase":"PHASE3","title":"QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2026-04-05","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":466},{"nctId":"NCT07256782","phase":"PHASE1, PHASE2","title":"A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-10-24","conditions":"Advanced Solid Tumor","enrollment":444},{"nctId":"NCT07198633","phase":"PHASE1, PHASE2","title":"A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-10","conditions":"Advanced Prostate Cancer","enrollment":212}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MHB088C"],"phase":"phase_3","status":"active","brandName":"QLC5508","genericName":"QLC5508","companyName":"Qilu Pharmaceutical Co., Ltd.","companyId":"qilu-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"QLC5508 is a small molecule drug that targets the molecular target. Used for unknown.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}